Publications by authors named "Samia Hajem"

Claim this Profile
A
Absence of significant clinical benefit for a systematic routine creatine phosphokinase measurement in asymptomatic patients treated with anti-programmed death protein (ligand) 1 immune checkpoint inhibitor to screen cardiac or neuromuscular immune-related toxicities.
Samia Hajem, Stéphane Ederhy, Stéphane Champiat, Frédéric Troalen, Alexis Nolin-Lapalme

Eur J Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis